The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | The evolution of BTOG and thoracic oncology care in the UK
The British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, celebrated a record number of delegates. Here, Ken O’Byrne, founding Chair and former President of BTOG, discusses the history of the organization, which hosted its 16th Annual Conference in 2018. Prof. O’Byrne, of Princess Alexandra Hospital & Queensland University of Technology, Brisbane, Australia, highlights the need for the group and the benefits which it has brought to the care of patients with thoracic malignancies in the UK. He reflects upon the changing practice for lung cancer care in the UK, and looks towards the future with immunotherapy combinations and removing the stigma of lung cancer as an incurable disease.
